Tobacco giant looks to the future with $1.8bn stake in cannabis company

Altria has turned its theoretical exploration of the cannabis sector into reality with a $1.8bn investment in the Cronos Group, a vertically integrated cannabis company.
US tobacco giant Altria has bought a 45% stake in the Canadian company with the option to take a majority 55% stake within the next four years if it chooses – essentially making the deal a potential acquisition rather than simply an investment.
It will also have the right to appoint four of the seven directors of Cronos following the deal closing. Altria chairman and CEO Howard Willard said Cronos would become Altria’s exclusive partner in the emerging global cannabis category.
Mike Gorenstein, chairman, president and CEO of Cronos, said: “The proceeds from Altria’s investment will enable us to more quickly expand our global infrastructure and distribution footprint, while also increasing investments in R&D and brands.”

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ Tobacco giant looks to the future with $1.8bn stake in cannabis company ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Tobacco giant looks to the future with $1.8bn stake in cannabis company ”






      Altria has turned its theoretical exploration of the cannabis sector into reality with a $1.8bn investment in the Cronos Group, a vertically integrated cannabis company.
      US tobacco giant Altria has bought a 45% stake in the Canadian company with the option to take a majority 55% stake within the next four years if it chooses – essentially making the deal a potential acquisition rather than simply an investment.
      It will also have the right to appoint four of the seven directors of Cronos following the deal closing. Altria chairman and CEO Howard Willard said Cronos would become Altria’s exclusive partner in the emerging global cannabis category.
      Mike Gorenstein, chairman, president and CEO of Cronos, said: “The proceeds from Altria’s investment will enable us to more quickly expand our global infrastructure and distribution footprint, while also increasing investments in R&D and brands.”

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik